Needham Downgrades Cantel Medical (CMD) to Hold


Needham analyst Michael Matson downgraded Cantel Medical (CMD) to Hold today. The company’s shares closed last Tuesday at $83.87, close to its 52-week high of $89.10.

According to TipRanks.com, Matson is a 5-star analyst with an average return of 15.0% and a 68.4% success rate. Matson covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Cardiovascular Systems, and Zimmer Biomet Holdings.

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Cantel Medical with a $77.50 average price target, a -9.9% downside from current levels. In a report released yesterday, Sidoti also downgraded the stock to Hold with a $85.00 price target.

See today’s analyst top recommended stocks >>

Cantel Medical’s market cap is currently $3.54B and has a P/E ratio of 112.90. The company has a Price to Book ratio of -9.58.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Cantel Medical Corp. engages in the development and manufacture of infection prevention products and services in the healthcare market. It operates through the following business segments: Medical, Life Sciences, Dental and Dialysis. The Medical segment designs, develops, manufactures, sells and installs a comprehensive offering of products and services comprising a complete circle of infection prevention solutions. The Life Sciences segment designs, develops, manufactures, sells and installs water purification systems for medical, pharmaceutical and other bacteria controlled applications. The Dental segment designs, manufactures, sells, supplies and distributes a broad selection of infection prevention healthcare products, the majority of which are single-use products used by dental practitioners. The Dialysis segment designs, develops, manufactures, sells and services reprocessing systems and sterilants for dialyzers as well as dialysate concentrates and supplies utilized for renal dialysis. Cantel Medical was founded on August 16, 1963 and is headquartered in Little Falls, NJ.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts